Detalles de la búsqueda
1.
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
Br J Cancer
; 130(3): 434-441, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38102226
2.
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study.
Lancet Oncol
; 22(7): 946-958, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34143969
3.
Predicting Chemotherapy Toxicity in Older Patients with Cancer: A Multicenter Prospective Study.
Oncologist
; 25(10): e1516-e1524, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32329131
4.
Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO).
BMC Cancer
; 19(1): 766, 2019 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31382926
5.
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities.
BMC Cancer
; 19(1): 636, 2019 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31253132
6.
Radium-223 international early access program: results from the Spanish subset.
Future Oncol
; 14(1): 41-50, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29232987
7.
A Review of Recent Advances in the Management of Alzheimer's Disease.
Cureus
; 16(4): e58416, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38756263
8.
Different outcomes among patients with intermediate-risk metastastic renal cell carcinoma treated with first-line tyrosine-kinase inhibitors.
Clin Transl Oncol
; 26(2): 532-537, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37505371
9.
Case-control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study.
Clin Transl Oncol
; 26(3): 732-738, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37556096
10.
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).
Target Oncol
; 2024 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704759
11.
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Eur Urol Oncol
; 7(1): 102-111, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481365
12.
Phosphorylated S6 as an immunohistochemical biomarker of vulvar intraepithelial neoplasia.
Mod Pathol
; 26(11): 1498-507, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23765247
13.
Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma.
Gynecol Oncol
; 130(3): 545-9, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23747330
14.
Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib.
Clin Genitourin Cancer
; 21(3): e166-e174, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610891
15.
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Minerva Urol Nephrol
; 75(4): 460-470, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37530662
16.
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Target Oncol
; 18(4): 559-570, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37369815
17.
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).
Clin Genitourin Cancer
; 21(5): e309-e319.e1, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062658
18.
Targeting the endothelin axis in prostate carcinoma.
Tumour Biol
; 33(2): 421-6, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22203496
19.
Immunomarkers in gynecologic cytology: the search for the ideal 'biomolecular Papanicolaou test'.
Acta Cytol
; 56(2): 109-21, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22378072
20.
Comparison of 2-Weekly and 3-Weekly Dosing of Docetaxel in Metastatic Prostate Cancer.
Clin Genitourin Cancer
; 20(4): 363-370, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35317987